Earnings History Data for Day One Biopharmaceuticals, Inc. (DAWN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-10-2024 | AH | DAWN | Day One Biopharmaceuticals, Inc. | 1,420 | 0.38 | -0.20 | -0.54 | Day One Biopharmaceuticals reports Q3 results [10/30/2024 4:08 PM] |
14.71 | 0.24 (1.69%) |
15.94 | 1.47 (10.16%) |
10.90 - 18.07 | 3,591,118 | 850,000 | 57,994 | ||
| 30-07-2024 | PM | DAWN | Day One Biopharmaceuticals | 1,401 | -0.05 | -0.67 | 0.00 | Day One Biopharmaceuticals GAAP EPS of -$0.05, revenue of $8.19M [7/30/2024 9:35 AM] |
15.12 | -0.23 (-1.53%) |
16.00 | 0.64 (4.17%) |
9.67 - 18.07 | 2,945,034 | 900,000 | 33,834 | ||
| 26-02-2024 | AH | DAWN | Day One Biopharmaceuticals | 1,267 | -0.64 | -0.57 | 0.00 | Day One Biopharmaceuticals reports Q4 results [2/26/2024 5:14 PM] |
17.33 | 1.68 (10.73%) |
15.99 | 0.34 (2.17%) |
9.67 - 20.39 | 732,588 | 390,000 | 959 | ||
| 07-08-2023 | AH | DAWN | Day One Biopharmaceuticals | 946.00 | -0.61 | -0.60 | 0.00 | Day One Biopharmaceuticals GAAP EPS of -$0.61 in-line [8/7/2023 5:39 PM] |
13.09 | 0.72 (5.82%) |
12.37 | 0.0 (0.00%) |
10.84 - 28.35 | 457,368 | 640,000 | 10,656 | ||
| 01-05-2023 | PM | DAWN | Day One Biopharmaceuticals | 890.00 | -0.59 | -0.60 | 0.00 | 14.48 | 2.08 (16.77%) |
0.0 | 0.0 (0.00%) |
5.44 - 28.35 | 2,034,945 | 1,030,000 | 0 | |||
|
|
||||||||||||||||||
| 07-11-2022 | AH | DAWN | Day One Biopharmaceuticals | 1,423 | -0.53 | -0.53 | 0.00 | Day One Biopharmaceuticals GAAP EPS of -$0.53 [11/7/2022 5:15 PM] |
19.74 | 0.26 (1.33%) |
19.48 | 0.0 (0.00%) |
5.44 - 28.35 | 443,532 | 510,000 | 17,298 | ||
| 04-08-2022 | AH | 4:30 PM ET (Aug 4) |
DAWN | Day One Biopharmaceuticals | 1,287 | -0.60 | -0.49 | 0.00 | Day One Biopharmaceuticals GAAP EPS of -$0.60 [8/4/2022 5:43 PM] |
23.64 | 3.19 (15.60%) |
20.50 | 0.05 (0.24%) |
5.44 - 28.70 | 928,658 | 350,000 | 685 | |
| 12-05-2022 | AH | DAWN | Day One Biopharmaceuticals | 475.00 | -0.48 | -0.39 | 0.00 | Day One Biopharmaceuticals GAAP EPS of -$0.48 misses by $0.08 [5/12/2022 5:12 PM] |
7.50 | 0.55 (7.91%) |
6.95 | 0.0 (0.00%) |
6.53 - 28.70 | 349,901 | 280,000 | 539 | ||
| 08-11-2021 | AH | DAWN | Day One Biopharmaceuticals | 1,608 | -0.33 | -0.28 | 0.00 | Day One Biopharmaceuticals EPS misses by $0.07 [11/8/2021 5:22 PM] |
23.73 | -1.10 (-4.43%) |
0.0 | 0.0 (0.00%) |
17.19 - 28.70 | 43,988 | 60,000 | 0 | ||